President & CEO of Insmed Inc (INSM, Financial) William Lewis bought 15,700 shares of INSM on 11/01/2018 at an average price of $15.9 a share. The total cost of this purchase was $249,630.
Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases. Insmed Inc has a market cap of $1.26 billion; its shares were traded at around $16.33 .
CEO Recent Trades:
- President & CEO William Lewis bought 15,700 shares of INSM stock on 11/01/2018 at the average price of $15.9. The price of the stock has increased by 2.7% since.
Directors and Officers Recent Trades:
- Director Steinar J Engelsen bought 16,085 shares of INSM stock on 11/01/2018 at the average price of $15.79. The price of the stock has increased by 3.42% since.
- Chief Commercial Officer Roger Adsett bought 3,000 shares of INSM stock on 11/01/2018 at the average price of $15.97. The price of the stock has increased by 2.25% since.
For the complete insider trading history of INSM, click here
.